Call for expansion of antiretroviral coverage by Indian diplomat

6 June 2019
hiv_aids_big

An important player in the global fight against AIDS, India has called for expanding antiretroviral therapy coverage to combat HIV/AIDS. Emphasising the importance of continued political commitment, a senior diplomat has said competing financing demands and changing priorities should not affect efforts to provide adequate resources to fight HIV/AIDS, reports The Pharma Letter’s India correspondent.

Taking a lead in the global fight against AIDS, India is supplying the world with two-thirds of the drugs to treat those infected with HIV, according to Indian diplomat Paulomi Tripathi.

Speaking at the UN General Assembly, Ms Tripathi, a First Secretary in India's UN mission said these affordable generic medicines have helped scale up access to treatment across developing countries, as almost two-thirds of the antiretroviral drugs used globally are supplied by the Indian pharmaceutical industry.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical